EXPANSION THERAPEUTICS, INC.

Profile

Company Names

EXPANSION THERAPEUTICS, INC.

Addresses

555 HERITAGE DRIVE, SUITE 150, JUPITER, FL 33458

491 PINE NEEDLES DRIVE, DEL MAR, CA 92014

Phone Numbers

561-898-1515
(650) 430-5836

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$78,337,879.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-09-27 
$48,032,016.00 
$80,053,360.00 
$32,021,344.00 
Equity 
2
2017-12-18 
$25,305,863.00 
$55,305,863.00 
$30,000,000.00 
Equity 
1
2016-11-28 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MATTHEW 
 
DISNEY 
DIRECTOR
EXPANSION THERAPEUTICS, INC.   |  RIBONAUT THERAPEUTICS, INC.
MATTHEW 
 
DISNEY, PH.D. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.
KEVIN 
 
FORREST 
EXECUTIVE OFFICER, DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  EXPANSION THERAPEUTICS, INC.
KEVIN 
 
FORREST, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
EXPANSION THERAPEUTICS, INC.   |  KATE THERAPEUTICS INC.
JASON 
 
HAFLER 
DIRECTOR
NEUROVIA, INC.   |  EXPANSION THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  ESCIENT PHARMACEUTICALS INC   |  ABCURO, INC.   |  MATCHPOINT THERAPEUTICS INC.   |  CHARACTER BIOSCIENCES, INC.   |  STAR THERAPEUTICS LLC
JASON 
 
HAFLER, PH.D. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.
YUJIRO 
 
HATA 
DIRECTOR
IDEAYA BIOSCIENCES, INC.   |  EXPANSION THERAPEUTICS, INC.   |  XENCOR INC
YUJIRO 
 
HATA, M.B.A. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.
CAMPBELL 
 
MURRAY, M.B.B.S., M.B.A. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.
ANDY 
 
PHILLIPS, PH.D. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.
SCOTT 
 
ROCKLAGE 
EXECUTIVE OFFICER, DIRECTOR
RENNOVIA INC   |  PULMATRIX INC   |  5AM CO-INVESTORS III, L.P.   |  ACHAOGEN INC   |  RELYPSA INC   |  WAVERX INC   |  SEMPRUS BIOSCIENCES CORP   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  KINESTRAL TECHNOLOGIES, INC.   |  NOVIRA THERAPEUTICS, INC.   |  5AM CO-INVESTORS IV, L.P.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  EXPANSION THERAPEUTICS, INC.   |  ALBAMUNITY, INC.
SCOTT 
 
ROCKLAGE, PH.D. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.
BETH 
 
SEIDENBERG, M.D. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.   |  KATE THERAPEUTICS INC.   |  ELECTRA THERAPEUTICS, INC.
RENATO 
 
SKERLJ, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
EXPANSION THERAPEUTICS, INC.
PAUL 
 
STONE 
EXECUTIVE OFFICER
HOMOLOGY MEDICINES, INC.   |  IDEAYA BIOSCIENCES, INC.   |  EXPANSION THERAPEUTICS, INC.   |  ASSAY DEPOT INC   |  ALPHA MEDIA HOLDINGS LLC
LAURA 
 
TADVALKAR, PH.D. 
DIRECTOR
EXPANSION THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-10-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-27 
2018-01-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-18 
2017-06-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-28 
2016-12-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#